Samsara BioCapital eyes $200M opportunity fundnews2025-10-10T10:40:27+00:00October 10th, 2025|Endpoints News|
Altos Labs is testing anti-aging therapies in organs kept alive outside the bodynews2025-10-09T19:55:46+00:00October 9th, 2025|Endpoints News|
Evommune files for IPO to fund two Phase 2 autoimmune drugsnews2025-10-09T19:26:14+00:00October 9th, 2025|Endpoints News|
AstraZeneca breaks ground on Virginia plant after Trump warns drugmakers to build or face tariffsnews2025-10-09T16:30:13+00:00October 9th, 2025|Endpoints News|
AviadoBio, UgeneX Therapeutics ink up to $413M deal; Apogee’s $300M stock salenews2025-10-09T15:19:02+00:00October 9th, 2025|Endpoints News|
Former Moderna leaders raise $325M for biotech venture firm Ascenta Capitalnews2025-10-09T15:09:14+00:00October 9th, 2025|Endpoints News|
What’s behind Amazon’s in-person pharmacy playnews2025-10-09T14:41:26+00:00October 9th, 2025|Endpoints News|
Chinese biotechs work on cheaper alternatives to $2M Zolgensmanews2025-10-09T14:00:08+00:00October 9th, 2025|Endpoints News|
Otsuka Precision Health buys maternal meditation platform Mindful Mamasnews2025-10-09T13:32:57+00:00October 9th, 2025|Endpoints News|
Mammoth Biosciences plans first trial of triglyceride-lowering gene editing therapynews2025-10-09T13:30:56+00:00October 9th, 2025|Endpoints News|
